The Xeroderma pigmentosum complementation group C (XPC) complex is a versatile factor involved in both nucleotide excision repair and transcriptional coactivation as a critical component of the NANOG, OCT4, and SOX2 pluripotency gene regulatory network. Here we present the structure of the human holo-XPC complex determined by single-particle electron microscopy to reveal a flexible, ear-shaped structure that undergoes localized loss of order upon DNA binding. We also determined the structure of the complete yeast homolog Rad4 holo-complex to find a similar overall architecture to the human complex, consistent with their shared DNA repair functions. Localized differences between these structures reflect an intriguing phylogenetic divergence in transcriptional capabilities that we present here. Having positioned the constituent subunits by tagging and deletion, we propose a model of key interaction interfaces that reveals the structural basis for this difference in functional conservation. Together, our findings establish a framework for understanding the structure-function relationships of the XPC complex in the interplay between transcription and DNA repair.
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transcription | stem cells | DNA repair | structure | biochemistry G enomes of living organisms serve two primary functions: as vehicles for hereditary information and as the template for gene products involved in an organism's development and responses to environmental stimuli. Vital to maintaining the health of genomes in the face of intrinsic and extrinsic sources of DNA damage are a suite of DNA repair pathways, each dedicated to handling specific lesions. Similarly, proper use and expression of this essential genomic information is regulated by a host of transcription factors, chromatin remodelers, and epigenetic modifiers and readers (1) . The Xeroderma pigmentosum complementation group C (XPC) protein complex performs crucial roles in both of these capacities by participating in nucleotide excision repair (NER) (2) and base excision repair (BER) (3) , as well as transcriptional regulation (4) and other processes (5) .
The XPC complex is one of seven XP complementation groups A-G and is composed of the 125-kDa XPC, the 58-kDa RAD23B (Rad23 homolog B; also known as HHR23B), and the 18-kDa CETN2 (Centrin2) subunits (2) . RAD23B and CETN2 associate tightly with XPC and stabilize both its DNA repair (6) (7) (8) (9) (10) and stem cell coactivator functions (4) . The XPC complex is the initiator and main DNA damage sensor in global genome nucleotide excision repair (GG-NER), one of two branches of the nucleotide excision repair pathway that repairs a wide array of bulky, helixdistorting lesions (2, 11) ; the second form of NER or transcription-coupled repair (TC-NER) targets lesions blocking transcription to reactivate proper gene expression (2, 12) . Defects in GG-NER lead to photosensitivity and a predisposition to certain cancers in animal models and in human patients with Xeroderma pigmentosum (13) . In conjunction with the UV-damage DNA-binding protein (UV-DDB) (2, 12) , the XPC complex recruits >30 downstream factors, such as XPA (14) , TFIIH (15, 16) , and the endonucleases XPF and XPG to remove these adducts (2, 11). In addition to its role in GG-NER, XPC is also involved in base excision repair (BER). BER is responsible for removing primarily non-helix-distorting lesions from the genome (2) . In BER, the XPC complex helps repair oxidative damage by stimulating the activities of DNA glycosylases such as OGG1 and TDG (3) to target lesions including 8-oxoguanine, independently of other downstream GG-NER factors (17) .
More recently, the XPC complex has also been found to perform crucial duties in the regulation of gene transcription, the second primary function of the genome. In embryonic stem cells (ESCs), the XPC complex acts as a coactivator to enhance the expression of OCT4-and SOX2-driven pluripotency genes, most notably NANOG (4), buttressing the gene regulatory network that establishes and maintains the unique self-renewal and pluripotency properties of ESCs. The XPC complex performs its coactivator functions independently of DNA binding (4, 18) , presumably by bridging interactions between the sequence-specific transcription factors OCT4 (octamer-binding transcription factor 4; also known as POU5F1) and SOX2 [SRY (sexdetermining region Y)-box 2] and the general transcriptional machinery, such as TFIID and RNA pol II, thus following a mechanism reminiscent of that of other coactivator complexes
Significance
Embryonic or pluripotent stem cells are unique in their ability to self-renew in culture and to generate all lineages of an adult organism, making them valuable tools for modeling early developmental processes and for developing regenerative medicine technologies. An important factor in controlling the expression of pluripotency genes is the Xeroderma pigmentosum complementation group C (XPC) DNA repair complex. This study presents, to our knowledge, the first complete structures of different XPC complexes by electron microscopy to establish an important framework for a molecular understanding of XPC's two primary functions. In conjunction with our biochemical findings, we synthesize a model of how XPC performs both its evolutionarily conserved DNA repair function and its evolutionarily nonconserved transcription function.
such as Mediator and p300/CBP (19) . In a separate study, XPC was found to localize to active but not to inactive RNA pol IIdependent gene promoters in the absence of exogenous genotoxic stress (11, 20) .
Although both the DNA repair and transcriptional functions of mammalian XPC complexes have been characterized biochemically and genetically, 3D structural information of the holo-complex has been unavailable. The partial crystal structure of Rad4, the yeast homolog of the human XPC subunit, in complex with the Rad4-interaction domain of yeast Rad23, has provided information helpful toward an understanding of Rad4/ XPC's biochemical behavior and of certain phenotypic outcomes (18, 21) . However, given XPC's low sequence homology with the yeast homolog Rad4 (21, 22) , the absence of key domains in the available crystal structure, and the divergence of requirements for transcriptional vs. repair activities (4, 15, 18, 23) , structural information of the complete, three-subunit, native human XPC complex is much needed for an understanding of the functional versatility of the XPC complex. At present, no information has been reported on the overall architecture of the XPC holocomplex, the possible large-scale conformational rearrangements in XPC upon DNA-binding, or the extent of structural conservation of the human XPC complex with homolog complexes.
Here we address the lack of structural data on human XPC using 3D single-particle reconstruction by electron microscopy (EM) to characterize the overall architecture of XPC, as well as genetic tagging and computational docking to locate the relative positions of its constituent subunits. We also assess the conformational changes to the complex upon binding to DNA. Given the evolutionary conservation of GG-NER (24), we queried the extent of structural and functional conservation over evolutionary time by solving the structure of the complete yeast homolog Rad4 complex and testing whether the OCT4/SOX2 transcriptional coactivation function is supported by the yeast complex. Together with existing biochemical data (14-16, 23, 25) , we sought to identify the approximate regions of contact between the XPC complex and its partner proteins OCT4, SOX2, XPA, and TFIIH.
Results
Reconstitution of the Human XPC Complex. We purified the complete, three-subunit human XPC-RAD23B-CETN2 complex (Fig.  1A ) expressed in Sf9 insect cells using a two-step affinity purification procedure (Fig. S1 A and B) . SDS/PAGE analysis indicated that the purified complex was nearly homogeneous and stoichiometric (Fig. S1B, Left) . This result is consistent with previous data showing that XPC and RAD23B interact in a 1:1 ratio (26) and that XPC and CETN2 also interact in a 1:1 ratio (27, 28) . Furthermore, a 1:1:1 stoichiometry is consistent with the size of the ∼200-kDa product we observe for the cross-linked complex (Fig.  S1B, Right) .
Initial attempts at negative stain EM data collection were hampered by the extremely heterogeneous appearance of the particles in both size and shape (data not shown). These results suggested that the complex was either unstable during EM sample preparation and/or suffered from extreme conformational flexibility. To overcome these limitations, we optimized cross-linking conditions across temperature, incubation time, and cross-linker concentration to identify the minimum requirements for achieving complete subunit incorporation as detected by Coomassie staining (for more details, see SI Materials and Methods, Expression and Purification of XPC/Rad4 Complexes). These particular conditions were then used for subsequent negative stain sample preparation, followed by data collection and single particle analysis ( Two-dimensional reference-free class averages (Fig. S2B ) show C-shaped views, multilobed structures, and some very small, compact, globular shapes, with most of the particles having an elongated appearance. Such elongated shapes would be consistent with our observation that the XPC complex runs as a relatively broad peak centered at 275 kDa on a size-exclusion column, slightly larger than its mass of ∼200 kDa ( Fig. 1A and Fig. S1 B and C).
Ab Initio 3D Reconstruction of the Human XPC Complex by Random
Conical Tilt and Subunit Localization. We used random conical tilt (29) (Fig. S1 D-G) to generate an ab initio 3D reconstruction of the human XPC complex (Fig. 1B and Fig. S2 ). Handedness and robustness of our EM reconstruction was supported by the results of the freehand test (30) using projection-matching of particle pairs at 0°and 30°tilt, which indicated that 40% of particles fall within 26 degrees of the expected tilt angle (Fig. S3D) . The structure is ∼170 Å by ∼100 Å by ∼70 Å and roughly resembles the shape of a human ear (Fig. 1B) . To localize the position of the CETN2 subunit within the reconstruction, we followed two parallel strategies: visualization of a complex that included a maltosebinding protein (MBP) tag at the N terminus of CETN2, and visualization of a complex lacking the CETN2 subunit ( docked (31) into the upper end of the "ear" in an orientation such that the C terminus of Rad4 points downward toward the "earlobe." In further agreement with this subunit organization, docking of the CETN2 was placed in the earlobe by objective, automatic docking using Situs (31) (Fig. 1E) . Based on the orientation of the Rad23 termini observed in the Rad4/Rad23 crystal structure, we also indicate the predicted, approximate locations of the UbL, UBA1, and UBA2 subunits of RAD23B that are not observed in the Rad4/Rad23 crystal structure (Fig. 1E) .
To ensure that the cross-linking and the use of stain did not significantly compromise the integrity of the structure obtained, we also analyzed the native, uncross-linked complex and used cryo-electron microscopy (cryo-EM). The native complex in phosphotungstate stain and the cross-linked complex under cryo conditions were all consistent with the cross-linked complex under negative stain conditions (Fig. 1B and Fig. S3 A-C) . Although the native complex appears to have better definition between the earlobe and the rest of the structure, this difference density is only present at 2σ and not at the statistically significant 3σ (Fig. S3C) .
The low resolution of our reconstruction (∼25 Å) suggested that the XPC complex may be flexible and adopt multiple conformations. To gain an understanding of the possible range of conformational states, we used a large data set of ∼210,000 particles and performed 3D sorting and classification using RELION (32) to produce three distinct structures representing the range of XPC conformations ( Fig. 2A) , followed by Situs docking using available crystal structures. The XPC complex appears to be partitioned between a more elongated ( Fig. 2A, Top) and more compact states ( Fig. 2A, Middle and Bottom). Threedimensional reprojections of these three models match referencefree 2D class averages (Fig. 2B) .
Structural Changes Following DNA Binding. To visualize possible structural changes in the human XPC complex upon binding to DNA, we used a monomeric avidin and biotinylated-DNA affinity purification strategy to isolate only DNA-bound XPC molecules ( Fig. S4 A and B) . The 48-bp DNA bubble mismatch duplex was chosen from a validated EMSA probe (22) that demonstrated one of the strongest affinities for the XPC complex. Comparison of the reconstructions obtained from the apo vs. DNA-bound samples indicates that the addition of DNA primarily affected the density region immediately above the "earlobe" (Fig. 3A) . Addition of DNA to XPC did not appear to lock the structure into a single conformation because the 2D class averages (Fig.  3B ) and the resolution of ∼24 Å are similar to those we observed for the apo complex. The changes observed are consistent with a possible movement of the BH domains of XPC toward the region of DNA-binding. This assessment is based on comparisons between the changes imposed by DNA binding in the Rad4 crystal structure and the position of the crystal structure docked into the EM density either as the intact Rad4/Rad23 crystal structure (Fig. 3A) or with the C-terminal portion of the Rad4 TGD domain considered separately from the N-terminal portion to better reflect structural homology with the human XPC, which contains an insertion in its TGD domain (Figs. S4C and S5 A and B) . A second interesting possibility is that certain regions of RAD23B become disordered upon DNA-binding, thus resulting in the observed loss of density; this is consistent with the finding that some regions of Rad23 that are ordered in the apo Rad4/Rad23 crystal structure becoming disordered upon binding DNA (21) .
The XPC complex has been demonstrated to bind other substrates as well, such as single-stranded DNA (33) . Therefore, we also prepared ssDNA-bound XPC molecules using the same strategy of biotinylated-DNA pull-down (Fig. S4 A and B) . Threedimensional difference density analysis indicates that this structure is nearly indistinguishable from the mismatch-DNA-bound XPC complex (Fig. S4D) .
Conservation of Structure and Function. The human XPC complex (XPC, RAD23B, CETN2) and the yeast homolog Rad4 complex (Rad4, Rad23, Rad33; ref. 34) appear to function equivalently in nucleotide excision repair, given their similar binding properties to damaged DNA (22) . These two complexes are also thought to be structurally similar based on strong sequence homology between human RAD23B and yeast Rad23 (6) and between human CETN2 and the purported yeast CETN2 homolog Rad33 (Fig.  S5C) . Despite low sequence conservation overall between XPC and Rad4, these two proteins share sequence homology of key domains (35) and very similar predicted secondary structures ( Fig. S5 A and B) . To examine this question of structural conservation, we obtained a 3D reconstruction at ∼23 Å resolution of the complete yeast Rad4 complex (Fig. 4 A and B) . The overall architecture of the complexes from the two species is remarkably similar at both the 3D and 2D levels (Fig. 4 B-D , Right vs. Fig. 1B and Fig. S2 B and E), although there are small areas of difference between the human and yeast complexes, as seen in the 3D difference maps (Fig. 4C) . We posit that the region of difference density in the earlobe may be due to structural differences between the CETN2 and Rad33 homologs (Fig. 1E and Fig. S5C) .
The structural similarity between the human and yeast XPC/ Rad4 complexes suggested that other functions of the XPC complex, in particular its transcriptional roles in ES cells, might also be conserved. To our surprise, we observed that unlike the human and mouse XPC complexes, the Rad4 complex exhibited no coactivator activity in our in vitro transcription assay (Fig. 4E) and was completely incapable of forming a stable interaction with SOX2, the primary requisite activator for in vitro activation of NANOG gene transcription (4) (Fig. 4F) . Using information on XPC's interaction domains with partner proteins (14, 15, 25, 27, 36) , sequence homology between yeast Rad4 and human XPC (Fig. S5) , as well as the docking of the Rad4/Rad23 crystal structure, we were able to generate a model indicating the predicted locations of the interaction domains on the XPC complex (Fig. 5A ). These interaction domains are clustered on the top of the ear. Intriguingly, when we superimpose the regions of difference density between the human and yeast EM maps with the predicted interaction domains, we note that one such region is located near the OCT4-and SOX2-binding interfaces but not the DNA-binding residues in regions DNA-BD3-5 (Fig. 5B) , suggesting that these regions of difference may underlie the phylogenetic divergence in transcriptional activity between the human and yeast complexes.
Discussion
Our single particle analyses reveal an ear-like shape for the human XPC complex and indicate the existence of a range of conformational states for this DNA repair and stem cell coactivator complex ( Figs. 1 and 2) . We show that the yeast homolog Rad4 holo-complex has a similar overall architecture but small regions of difference compared with the human XPC complex that may reflect their functional nonequivalence in biochemical assays (Fig. 4) . Using labeling, mutational, and docking strategies, we localize the individual subunits of the complex within the structure (Fig. 1) . The binding to the two distinct DNA substrates used in this study resulted in a similar overall conformational change in the left domain immediately above the earlobe, which is consistent with previous observations in the Rad4/Rad23 crystal structures (21) (Fig. 3) .
Our study reveals the apparent flexibility of the XPC complex, in large part mirroring its functional versatility. The flexibility of the complex may stem, at least in part, from RAD23B, because certain regions of Rad23 were found to be disordered in the Rad4/ Rad23 crystal structure (21) . Part of the conformational heterogeneity seen in our EM structures may be due to variations in the interaction between the UbL and the equivalent UBA1 and UBA2 domains of RAD23B (Fig. 1A) . Some of the conformational variability may also originate from the XPC subunit. Structure prediction analysis (14) , limited proteolysis (14) , and NMR (37) identified several highly disordered regions: the N terminus (residues 1-154), the C terminus (residues 816-940), and a loop inserted into the TGD domain comprising residues 331-517. Finally, CETN2 may also contribute to this overall flexibility, because it can adopt different conformations depending on its metal-binding state (38) ; however, the resolution of the XPC-RAD23B subcomplex was not markedly improved, suggesting that this contribution to complex flexibility is minor, as would be expected for its relatively small mass contribution to the complex. The recently described requirement of RNA for the XPC complex to interact with its transcription partner SOX2 (25) invokes the idea of low-complexity domains or regions, perhaps interspersed throughout XPC, linking their inherent flexibility to a critical aspect of the XPC complex's function. The possibility that the mammalian-specific insertion within the TGD domain (residues 331-517; Fig. 1A and Fig. S5B ) could be partly responsible for some of the observed structural heterogeneity is particularly interesting.
With the use of an MBP-tag as a labeling strategy, as well as the exclusion of CETN2 from the complex, we were able to localize CETN2 to the earlobe of the structure ( Fig. 1 C and D) . Extending these findings, we used rigid-body docking in an unbiased manner to place the Rad4/Rad23 crystal structure at the top of the ear and the CETN2 crystal structure in the earlobe (Fig. 1E ). Attempts to tag the XPC and RAD23B subunits were not successful for a variety of reasons. The absence of CETN2 does not appear to impose large conformational rearrangements, as seen by the comparison between the full complex and the XPC-RAD23B subcomplex ( Fig. 1 B and D) . This observation is consistent with the lesser functional consequence of removing CETN2 than that of removing RAD23B in transcriptional coactivation assays, as well as with the inconsequential removal of the C-terminal CETN2-interaction domain on XPC (residues 814-940) (4) .
The similarity between the dsDNA-and ssDNA-bound structures is consistent with the fact that the XPC complex is capable of binding a large suite of different DNA structures, including UVinduced thymine dimers (2), mismatch bubbles (22) , ssDNAdsDNA junctions (39) , apurinic/apyrimidic (AP) sites (40) , and even undamaged duplex and certain single-stranded DNA substrates (33) . This similarity between different DNA-bound structures is also consistent with recent work describing a kinetic but not structural means of discrimination between damaged and undamaged DNA by Rad4 (41) . The reduction of density in our DNA-bound structures compared with the apo XPC complex reflects a conformational change consistent with two phenomena observed in the Rad4 crystal structure: (i) the C-terminal portion of Rad4 shifting toward the DNA substrate, and in the context of our docking, away from the region of reduced density (Fig. 3A and Fig. S4 C and E); (ii) portions of Rad23 originally contributing to ordered density in the apo crystal structure becoming disordered upon binding to DNA (21) . We are inclined to favor this latter observation to explain the DNA-induced changes to the XPC complex because the primary EM density difference we observe cannot easily be accounted for by the modest, ∼13-to 14-Å shift in Rad4 observed in the crystal structure (Fig. S5E) . Therefore, we propose that DNA binding by the XPC complex induces specific conformational changes and disorder of certain domains, possibly such as the UbL domain (Fig. 1E) .
The overall similarities between the human XPC structure and the yeast Rad4 structure, despite their divergent amino acid sequences, provide additional, indirect validation of the accuracies of the 3D models. Indeed, it seems quite remarkable that without requiring major changes to the overall evolutionarily conserved 3D shape and structure of the mammalian XPC complex, it has nevertheless adopted entirely new transcriptional coactivator functions in the context of ES cell regulatory pathways that are not relevant in yeast. The extent of structural conservation is consistent with their equivalence in repair (22) . Regions displaying differences may reflect the divergence in functional capabilities that we observe in a transcriptional context (Fig. 4) . Indeed, one of these regions at the top portion of the ear corresponds to residues homologous to those shown to interact with OCT4 and SOX2 (Fig.  5B, yellow) . Importantly, this region is well separated from DNAbinding residues (Fig. 5B , circled BD3-5; key residues in dark blue). The only close-by DNA-binding residues (BD3) are in fact not conserved and are not found in the human sequence (Fig.  S5B) . This structural separation-of-function suggests that the local degree of structural conservation, even at modest resolution, is predictive of functional convergence or divergence. From an evolutionary point of view, a conserved process, such as nucleotide excision repair, would be expected to exhibit functional conservation between the yeast and human XPC homologs, whereas a nonconserved process, such as regulating genes expressed in mammalian embryonic stem cells, would not. Indeed, a number of XPC mutations that have differential effects in DNA repair vs. transcription support this idea. For instance, although deletion of the N-terminal UbL domain of yRad23 (42) and the W690S mutation of XPC (18, 43) have adverse consequences on nucleotide excision repair capabilities, respective mutations in XPC did not affect the ability to coactivate transcription (4) (Y.W. F., unpublished). Similarly, although the N and C termini of XPC are critical for recruitment and stimulation of TFIIH at sites of damage for global nucleotide excision repair (15, 16, 44, 45) , the removal of the N-and C-terminal TFIIH-binding domains of XPC (residues 1-195 and 814-940, respectively) only impacts repair but not transcriptional activity (4, 25) .
Reflecting the ever-expanding repertoire of reported XPC roles is the number of known physical and functional interactors of the XPC complex, e.g., TFIIH (15, 16) , OGG1 (23), TDG (3), SOX2 (4, 25) (Fig. 4) , and OCT4 (4, 25), among others (46) . It is possible that the XPC complex serves as a coactivator not just for OCT4 and SOX2, especially given that its transcriptional activities do not appear to be cell-type-restrained (20) ; therefore, the list of XPC's functional and physical partners is likely to grow. Although the residues on XPC through which some of these known interactions occur have been mapped, there is a degree of overlap between some of these regions, suggesting the need for more fine-tuned characterization and structural elucidation in the future (Fig. 1A) . Our recent work describing the involvement of RNA in mediating the XPC-SOX2 interaction adds an additional and potentially intriguing dimension to future structural studies in this regard (25) . Additionally, it would be interesting to explore whether structural changes are imposed on the XPC complex upon binding to its partner proteins; further biochemical and structural work to assemble such larger protein assemblies is required. In summary, this work provides a structural framework for integrating biochemical and structural information into a mechanistic understanding of the XPC complex's undoubtedly complicated roles in DNA repair and transcriptional regulation.
Materials and Methods
Detailed methods can be found in SI Materials and Methods. XPC/Rad4 complexes were affinity purified from Sf9 cells. DNA-bound XPC samples were affinity purified using biotinylated DNA substrates. EM was performed using continuous carbon films and uranyl formate or phosphotungstate stain for negative stain. Leginon software (47) was used to collect images in a Tecnai F20 microscope equipped with a Gatan UltraScan 4000 camera. Data processing was performed primarily in the Appion pipeline (48) . Threedimensional reconstructions were performed using EMAN2 (49) and RELION (32) . Coimmunoprecipitation assays were performed in HEK293T cells. In vitro transcription assays were performed essentially as described (50) .
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